interferon alfa-n1

06/01/1998 - "[An observation on antiviral effect of IFN--alpha N1 (Wellferon) in patients with chronic hepatitis B]."
01/01/1991 - "[Results of the treatment of chronic hepatitis B with interferon alfa (wellferon)]."
12/01/1988 - "The aim of this study was to evaluate the efficacy of human lymphoblastoid interferon (Wellferon) in the treatment of chronic hepatitis B virus (HBV) infection. "
12/01/1988 - "The efficacy of human lymphoblastoid interferon (Wellferon) was studied in 25 patients with anti-HBe positive, HBV DNA positive chronic hepatitis B. "
12/01/1988 - "The efficacy of human lymphoblastoid interferon (Wellferon) therapy was measured in 20 children with chronic hepatitis B with or without pretreatment with prednisolone. "

10/01/1991 - "The efficacy of systemic interferon-alpha (IFN-alpha n1; Wellferon) treatment on genital human papillomavirus (HPV) infections was studied in a double-blind, placebo-controlled trial. "
10/01/1991 - "Systemic alpha-interferon (Wellferon) treatment of genital human papillomavirus (HPV) type 6, 11, 16, and 18 infections: double-blind, placebo-controlled trial."
01/01/1991 - "In studies of the inhibitory effect of IFN-alpha (Wellferon) on acute human immunodeficiency virus type 1 infection of human T-cell lines, we found that in C3 cells, the 50% effective concentration was 9 U/ml and the 90% effective concentration was 310 U/ml. There was no apparent accumulation of intracellular particles detected by p24 antigen levels or by processing the cells for electron microscopy. "
12/01/1988 - "The aim of this study was to evaluate the efficacy of human lymphoblastoid interferon (Wellferon) in the treatment of chronic hepatitis B virus (HBV) infection. "
01/01/1986 - "Lymphoblastoid interferon (Wellferon), a combination of at least 8 alpha-interferons, has been shown to be effective therapy in male chronic carriers of HBV infection, resulting in the loss of HBeAg and HBV-DNA in 50% of those treated. "

11/01/1988 - "This study demonstrates that parenterally administered Wellferon produces clearance of resistant genital warts in many patients, and that rates of clearance do not appear to vary between groups receiving moderate or low dose therapy."
11/01/1988 - "This multi-center trial compared two doses of parenterally administered interferon alpha-n1 (Wellferon) in men and women with recurrent/resistant genital warts. "
08/01/1988 - "This effect on serum lipids should be considered when interferon alfa-n1 is used in the treatment of genital warts."
08/01/1988 - "Nine men with refractory condylomata acuminata were treated with intramuscular interferon alfa-n1 and the effect on their serum lipid levels was noted. "
11/01/1988 - "Interferon alpha-n1 (Wellferon) for refractory genital warts: efficacy and tolerance of low dose systemic therapy."

10/01/1988 - "It appears that interferon alfa-n1 as an adjuvant to routine surgical management is effective in slowing the growth of respiratory papillomas."
10/01/1988 - "Randomized surgical adjuvant trial of interferon alfa-n1 in recurrent papillomatosis."

09/01/1997 - "Therapy of hepatitis C: interferon alfa-n1 trials."
09/01/1997 - "Early studies indicated that interferon alfa-n1 was effective against hepatitis C, and a meta-analysis of published trials indicated that it was equally likely as recombinant alpha interferons to produce an end-of-treatment biochemical and histological response. "